Bloodline Theatre Company’s production is staged in the capital next month
Bloodline Theatre Company brings its latest production, Panacea, back to the capital next spring, with a one-week engagement at Riverside Studios from 16 to 21 March 2026.
Following its sold-out debut at Cockpit Theatre in 2025, the production returns to Studio 3 for a limited run, continuing its powerful exploration of science, ethics, and social responsibility.
A Provocative New Drama
Panacea centres on Professor Augustus “Gus” Jamieson, a researcher with ASD who is developing a revolutionary infectious vaccine. As Gus balances academic pressure, personal ambition, and emotional connection, he is forced to confront the darker implications of scientific progress.
The play raises urgent questions about the cost of discovery, the limits of innovation, and the responsibilities that come with shaping humanity’s future.
Science Meets Theatre
The production is the result of a unique collaboration between microbiologist Andrew Singer and theatre-maker Christina James, whose background in psychoanalysis brings psychological depth to the work.
Inspired by real-world ethical dilemmas — from antibiotic resistance to emerging global viruses — Panacea draws on cutting-edge scientific research and debate. Developments in infectious vaccine technologies and environmental release strategies form the basis of a future where pandemics could be eliminated, but potentially at the cost of human choice and autonomy.
This provocative idea became the foundation for Gus’s story, first presented in January 2025.
Research-Led Support
The project has been supported by Digital Health Hub for AMR and ARREST-AMR, two initiatives funded through UK Research and Innovation.
Their backing reflects a shared belief in theatre as a powerful tool for communicating complex science in accessible and engaging ways, helping bring global health challenges into the cultural mainstream.
Panacea
Riverside Studios, Studio 3
101 Queen Caroline Street, London W6 9BN
Monday 16 March – Saturday 21 March 2026
Tickets available via Riverside Studios.
